A detailed history of Exodus Point Capital Management, LP transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 21,538 shares of STXS stock, worth $50,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,538
Holding current value
$50,614
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.76 - $2.35 $37,906 - $50,614
21,538 New
21,538 $44,000
Q1 2024

May 14, 2024

BUY
$1.74 - $3.16 $96,368 - $175,013
55,384 New
55,384 $145,000
Q2 2020

Aug 14, 2020

SELL
$2.71 - $5.47 $644,215 - $1.3 Million
-237,718 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.77 - $5.4 $278,068 - $848,345
157,101 Added 194.87%
237,718 $718,000
Q4 2019

Feb 14, 2020

BUY
$2.99 - $5.29 $241,044 - $426,463
80,617 New
80,617 $426,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $176M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.